PubRank

Kerstin Schwarzwaelder

Author PubWeight™ 34.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006 9.68
2 Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008 7.05
3 Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 2010 4.76
4 High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 2007 3.90
5 Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 2007 3.28
6 Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med 2009 2.19
7 Real-time definition of non-randomness in the distribution of genomic events. PLoS One 2007 1.14
8 Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy. Mol Ther 2011 1.04
9 Long-term regulation of genetically modified primary hematopoietic cells in dogs. Mol Ther 2011 0.88
10 Efficient marking of human cells with rapid but transient repopulating activity in autografted recipients. Blood 2005 0.87
11 Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples. Methods Mol Biol 2009 0.84
12 Corrigendum to "Long-term Regulation of Genetically Modified Primary Hematopoietic Cells in Dogs". Mol Ther 2016 0.75